MTMaria E. Tecos

Maria E. Tecos

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Maria E. Tecos has a total of 37 co-authors. Here are the top co-authors by number of shared publications:

  • Brad W. Warner

    Division of Pediatric Surgery, Department of Surgery, Washington University in St. Louis School of Medicine, St. Louis, MO 63110

    5 shared publications
  • Jun Guo

    Division of Pediatric Surgery, Department of Surgery, St. Louis Children's Hospital, Washington University in St. Louis School of Medicine, St. Louis, Missouri

    4 shared publications
  • Allie E. Steinberger

    Department of Surgery, Washington University School of Medicine, St. Louis, Missouri

    3 shared publications
  • Nicholas O. Davidson

    Division of Gastroenterology, Department of Medicine, Washington University in St. Louis School of Medicine, Washington University, St. Louis, Missouri

    3 shared publications
  • Allie E. Steinberger

    Department of Surgery, Barnes Jewish Hospital, Washington University in St. Louis School of Medicine, St. Louis, Missouri

    2 shared publications
  • Deborah C. Rubin

    Division of Gastroenterology, Department of Medicine, Washington University in St. Louis School of Medicine, Washington University, St. Louis, Missouri

    2 shared publications

Latest Publications

  • Open Access

    Cellular trafficking and fate mapping of cells within the nervous system after in utero hematopoietic cell transplantation

    by Matthew T. Grant, Hemanth Ramesh Nelvagal, Maria Tecos, Amal Hamed, Kerry Swanson, Jonathan D. Cooper, Jesse D. Vrecenak

    In utero hematopoietic cell transplantation (IUHCT) utilizes fetal immune tolerance to achieve durable chimerism without conditioning or immunosuppression during a unique window in fetal development. Though donor cells have been observed within the nervous system following in utero injection, the timeline and distribution of cellular trafficking across the blood-brain barrier following IUHCT is not well understood. We injected 20 × 106 adult bone marrow mononuclear cells intravenously at gestational age (GA) 12–17 days and found that donor cells were maximally concentrated in the brain with treatment between GA 13–14. Donor cell engraftment persisted within the brain at every timepoint analyzed and concentrated within the hindbrain with significantly more grafted cells than in the forebrain. Additionally, transplanted cells terminally differentiated into various nervous system cellular morphologies and also populated the enteric nervous system. This study is the first to document the timeline and distribution of donor cell trafficking into the immune-protected nervous system and serves as a foundation for the application of IUHCT to treat neurogenetic diseases.


  • Roles for Bile Acid Signaling and Nonsense-Mediated Ribonucleic Acid Decay in Small Bowel Resection-Associated Liver Injury

    by Maria E. Tecos, Allie E. Steinberger, Jun Guo, Deborah C. Rubin, Nicholas O. Davidson, Brad W. Warner


  • Open Access

    Emergent initial presentation of congenital malrotation with midgut volvulus in 68-year-old

    by Maria E Tecos, Margarita Pipinos, Brett H Waibel

    Congenital malrotation is a pathology nearly exclusive to the infant population. In the rare instance when it is diagnosed in an adult, it is typically associated with a longstanding history of gastrointestinal symptoms. Unfortunately, this unique presentation in an unexpected population has the potential to be confounding, leading to delayed or mismanaged care. Here, we describe an intriguing case of congenital malrotation complicated by midgut volvulus in a 68-year-old woman. Even more curious, the patient did not have a medical history plagued by abdominal complaints. Careful, comprehensive evaluation yielded appropriate surgical management via Ladd’s procedure and right hemicolectomy in this complex patient.


  • Disruption of Enterohepatic Circulation of Bile Acids Ameliorates Small Bowel Resection Associated Hepatic Injury

    by Maria E. Tecos, Allie E. Steinberger, Jun Guo, Deborah C. Rubin, Nicholas O. Davidson, Brad W. Warner


  • Open Access

    Intraoperative endoscopy-assisted tumor debulking in pediatric peutz-jeghers syndrome with early onset massive polyp burden phenotype

    by Maria E. Tecos, Matthew Ballweg, Andrew Huang-Pacheco, Angela Hanna, Abdalla Zarroug, Patrick Thomas

  • A novel maladaptive unfolded protein response as a mechanism for small bowel resection-induced liver injury

    by Allie E. Steinberger, Maria E. Tecos, Hannah M. Phelps, Deborah C. Rubin, Nicholas O. Davidson, Jun Guo, Brad W. Warner

    The unfolded protein response (UPR) is a complex adaptive signaling pathway activated by the accumulation of misfolded proteins in the endoplasmic reticulum (ER). ER stress (ERS) triggers a cascade of responses that converge upon C/EBP homologous protein (CHOP) to drive inflammation and apoptosis. Herein, we sought to determine whether liver injury and fibrosis after small bowel resection (SBR) were mediated by a maladaptive hepatic ERS/UPR. C57BL/6 mice underwent 50% proximal SBR or sham operation. Markers of liver injury and UPR/ERS pathways were analyzed. These were compared with experimental groups including dietary fat manipulation, tauroursodeoxycholic acid (TUDCA) treatment, distal SBR, and global CHOP knockout (KO). At 10 wk, proximal SBR had elevated alanine aminotransferase/aspartate aminotransferase (ALT/AST) (P < 0.005) and greater hepatic tumor necrosis factor-α (TNFα) (P = 0.001) and collagen type 1 α1 (COL1A1) (P = 0.02) than shams. SBR livers had increased CHOP and p-eIF2α, but were absent in activating transcription factor 4 (ATF4) protein expression. Low-fat diet (LFD), TUDCA, and distal SBR groups had decreased liver enzymes, inflammation, and fibrosis (P < 0.05). Importantly, they demonstrated reversal of hepatic UPR with diminished CHOP and robust ATF4 signal. CHOP KO-SBR had decreased ALT but not AST compared with wild-type (WT)-SBR (P = 0.01, P = 0.12). There were no differences in TNFα and COL1A1 (P = 0.09, P = 0.50). SBR-induced liver injury, fibrosis is associated with a novel hepatic UPR/ERS response characterized by increased CHOP and decreased ATF4. LFD, TUDCA, and ileocecal resection rescued the hepatic phenotype and reversed the UPR pattern. Global CHOP KO only partially attenuated liver injury. This underscores the significance of disruptions to the gut/liver axis after SBR and potentiates targets to mitigate the progression of intestinal failure-associated liver disease. NEW & NOTEWORTHY The unfolded protein response (UPR) is a complex signaling cascade that converges upon C/EBP-homologous protein (CHOP). Under conditions of chronic cellular stress, the UPR shifts from homeostatic to proapoptotic leading to inflammation and cell death. Here, we provide evidence that small bowel resection-induced liver injury and fibrosis are mediated by a maladaptive hepatic UPR. Low-fat diet, TUDCA treatment, and ileocecal resection rescued the hepatic phenotype and reversed the UPR pattern.


  • Distal Small Bowel Resection Yields Enhanced Intestinal and Colonic Adaptation

    by Maria E. Tecos, Allie E. Steinberger, Jun Guo, Brad W. Warner


  • Open Access

    Alterations in pancreatic islet cell function in response to small bowel resection

    by Cathleen M. Courtney, Zeenat A. Shyr, Zihan Yan, Emily Jean Onufer, Allie E. Steinberger, Maria E. Tecos, Lauren K. Barron, Jun Guo, Maria S. Remedi, Brad W. Warner

    After 50% proximal small bowel resection (SBR) in mice, we have demonstrated hepatic steatosis, impaired glucose metabolism without insulin resistance, and increased pancreatic islet area. We sought to determine the consequences of SBR on pancreatic β-cell morphology, proliferation, and expression of a key regulatory hormone, glucagon-like peptide-1 (GLP-1). C57BL/6 mice underwent 50% SBR or sham operation. At 10 wk, pancreatic insulin content and secretion was measured by ELISA. Immunohistochemistry was performed to determine structural alterations in pancreatic α-and β-cells. Western blot analysis was used to measure GLP-1R expression, and immunoassay was used to measure plasma insulin and GLP-1. Experiments were repeated by administering a GLP-1 agonist (exendin-4) to a cohort of mice following SBR. After SBR, there was pancreatic islet hypertrophy and impaired glucose tolerance. The proportion of α and β cells was not grossly altered. Whole pancreas and pancreatic islet insulin content was not significantly different; however, SBR mice demonstrated decreased insulin secretion in both static incubation and islet perfusion experiments. The expression of pancreatic GLP-1R was decreased approximately twofold after SBR, compared with sham and serum GLP-1, was decreased. These metabolic derangements were mitigated after administration of the GLP-1 agonist. Following massive SBR, there is significant hypertrophy of pancreatic islet cells with morphologically intact α- and β-cells. Significantly reduced pancreatic insulin release in both static and dynamic conditions demonstrate a perturbed second phase of insulin secretion. GLP-1 is a key mediator of this amplification pathway. Decreased expression of serum GLP-1 and pancreatic GLP-1R in face of no change in insulin content presents a novel pathway for enteropancreatic glucose regulation following SBR.NEW & NOTEWORTHY Metabolic changes occur following intestinal resection; however, the effects on pancreatic function are unknown. Prior studies have demonstrated that glucagon-like protein-1 (GLP-1) signaling is a crucial player in the improved insulin sensitivity after bariatric surgery. In this study, we explore the effect of massive small bowel resection on gut hormone physiology and provide novel insights into the enteropancreatic axis.


  • Updates on Prophylaxis for Deep Venous Thrombosis and Venous Thromboembolism

    by Maria Tecos, Keely Buesing

    Purpose To concisely present recommendations and guidelines for venous thromboembolism (VTE) treatment and prevention for common subgroups of surgical patients as a comprehensive reference for clinical surgical practice.Methods Thorough literature review, including the consensus guidelines and recommendations of various professional surgical societies, was evaluated and conglomerated to provide a comprehensive reference for practicing surgeons. Common surgical patient subgroups were investigated for differing recommendations. Recommendations, guidelines, and resources were tabulated into user-friendly formats for easy reference purposes.Results Substantial updates have been made to the recommendations for VTE prevention and treatment. The American College of Chest Physicians (ACCP) have updated their VTE recommendations. The Eastern Association for the Surgery of Trauma has also released updated recommendations regarding VTE management. The Society of American Gastrointestinal and Endoscopic Surgeons has recalled their own specific recommendations for VTE treatment and prophylaxis in support of tenth edition of the ACCP guidelines on the subject.Conclusions VTE affects up to 25% of hospitalized patients, with up to 30% of those experiencing complications. Risk stratification is important in choosing therapy for prevention and management of VTE. Management of VTE depends on precipitating factors and future risk of VTE progression versus bleeding. Low-molecular-weight heparin is the preferred anticoagulant for initial treatment of VTE. The tenth edition of ACCP VTE guidelines provides comprehensive management recommendations.